Armata Pharmaceuticals Inc. (ARMP)
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
e-STORAGE and Axpo Partner on First Joint Battery Project in Italy
ROMA Green Finance Advances Its Cornerstone AI/HPC Infrastructure Platform with a US$15 Million Powered-Land Investment in NXTGrid Compute Power
Accenture Significantly Increases Fiscal Year 2026 Share Repurchase Program by $2 Billion
Fury Announces Metallurgical Test Results for the Ninaaskumuwin Lithium Discovery with Potential Direct Shipping Ore Concentrate of 6.0% Li2O5 and 77% Recovery
Trustee report to the bondholders (Series 6) for 2025 - Strauss Lazar, Trust Company (1992) Ltd.
Ryder to Release Second Quarter 2026 Earnings on July 23, 2026
GCT Semiconductor Announces Strategic Commitment to Powering the AI-Edge Data Pipeline
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interests - Mr Gordon Blaikie
Change - Announcement of Appointment: Appointment of Executive Director and Group Chief Executive Officer - Ong Choon Yi (Wang Junyi)